A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
19 Jun 2023
19 Jun 2023
Historique:
pubmed:
14
2
2023
medline:
14
2
2023
entrez:
13
2
2023
Statut:
epublish
Résumé
Radical cure of
Identifiants
pubmed: 36778461
doi: 10.1101/2023.01.31.526483
pmc: PMC9915689
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI136511
Pays : United States
Organisme : Bill & Melinda Gates Foundation
ID : INV-031788
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201200031C
Pays : United States
Organisme : NIH HHS
ID : S10 OD026929
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Déclaration de conflit d'intérêts
Competing interests: TM and KC are employees of BioIVT. AH-C, ELF, and SAM are employees of the Novartis Institute for Tropical Disease, BC is an employee of MMV. All other authors have no competing interests.